Lv11
46 积分 2023-07-08 加入
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
59分钟前
待确认
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer
1个月前
已完结
Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response
1个月前
已完结
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
2个月前
已完结
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer
2个月前
已完结
皖公网安备34019202002308
